NM
The startup has developed a non-invasive drug-delivery device specifically for ENT treatments, targeting chronic sinusitis and chronic rhinosinusitis. This device enables patients to manage their condition effectively in a non-clinical setting, minimizing the need for invasive procedures and reducing side effects associated with systemic drugs.
Updated 18 months ago
Funding
$260K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
NS
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed a non-invasive drug-delivery device specifically for ENT treatments, targeting chronic sinusitis and chronic rhinosinusitis. This device enables patients to manage their condition effectively in a non-clinical setting, minimizing the need for invasive procedures and reducing side effects associated with systemic drugs.